Estimated that the global burden of melioisosis is 4.6 million disability-adjusted life-years (DALYs) pear year (Lancet Infect Dis. 2019 Aug;19(8):892-902)
Estimated that there are 165,000 human melioidosis cases per year worldwide, of which 89,000 die. (Nat Microbiol. 2016 Jan 1;1(1))
Led and supported a large series of publications describing current burden and challenges of melioidosis from melioidosis network in each country (21 publications; Trop Med Infect Dis. 2018;3(2):38)
Showed feasibility and initial outcomes of a multifaceted prevention programme of melioidosis in pilot groups of diabetic patients (PLoS Negl Trop Dis. 2018;12(9):e0006765)
Developed a rapid immunochromatography test (ICT) for POC detection of IgG antibodies to Hcp1 (J Clin Microbiol. 2018;56(8)).
Demonstrated that Burkholderia pseudomallei undergo phenotypic adaptation at the proteomic and transcriptomic levels in response to an increase in growth temperature (Paksanont S et al, Sci Rep. 2018;8(1):9167).
Reported that B. pseudomallei is commonly misidentified as Acinetobacter spp. and other bacteria even in the laboratory of a provincial hospital in northern Thailand ( Trans R Soc Trop Med Hyg. 2019 Jan 1;113(1):48-51).